UK Supreme Court grants BIA intervention request in plausibility case

The UK Supreme Court has granted the UK BioIndustry Association (BIA) permission to intervene in the case of Warner-Lambert Company v Generics and Actavis, which concerns the issue of ‘plausibility’.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

Warner-Lambert v Actavis: a summary from the UK Supreme Court hearing

21 February 2018 Infringement and plausibility were the biggest issues on the battleground in the UK Supreme Court’s hearing in a case dealing with second medical use patents, as Claire Phipps-Jones, Katie Cambrook and Rachel Mumby of Bristows report.

Big Pharma

UK Supreme Court issues Warner-Lambert v Actavis ruling

14 November 2018 The UK Supreme Court today dismissed Warner-Lambert’s appeal in its pregabalin patent dispute with Actavis, while clarifying the role of plausibility in the sufficiency of patent applications.

Big Pharma

UK biotech industry publishes manifesto ahead of UK election

12 November 2019 The UK BioIndustry Association has published a manifesto detailing its recommendations on how political parties can support innovation in the UK life sciences sector, ahead of the UK general election.